Company profile: Corgenix
1.1 - Company Overview
Company description
- Provider of in vitro diagnostic products, including ELISA tests and vascular disease assays (antiphospholipid antibody), engaged in research, development, manufacturing, and marketing in North America and internationally. Offers contract development, GMP/FDA-registered manufacturing, CAP/CLIA lab testing, quality and regulatory (ISO13485, FDA) services, and clinical trial management.
Products and services
- Contract Manufacturing: Corgenix produces private label diagnostic tests and its own IVD product lines in a GMP-compliant facility, supporting regulated production for North American and international markets
- Contract Development: Corgenix architects multi-platform diagnostic tests, executing assay validation, reproducibility testing, and bridging studies to confirm performance equivalence across chosen assay formats
- Clinical Laboratory Services: Corgenix operates a CAP/CLIA-certified laboratory delivering research services, clinical trial testing, and routine clinical testing services.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Corgenix
Jubilee Clinical Research
HQ: United States
Website
- Description: Provider of clinical research across diverse indications, including new antibiotic developments and the latest diabetic therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jubilee Clinical Research company profile →
Girindus
HQ: Germany
Website
- Description: Provider of solid-phase oligonucleotide manufacturing and customer-driven services for pharmaceutical clients, including process development, analytical method development, radiolabeling, cGMP-compliant scale-up, active ingredient manufacturing, and regulatory support, with expertise in both oligonucleotide and small molecule.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Girindus company profile →
Avid Bioservices
HQ: United States
Website
- Description: Provider of end-to-end biologics services, including mammalian protein process development, drug substance development, CGMP manufacturing from early stages to commercial scale, and analytical services; also specializes in viral vector design, optimization, and scalable production for gene therapy and vaccine applications. Expansion doubles capacity to service a $40m backlog and support owner Peregrine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avid Bioservices company profile →
Scorpius Biologics
HQ: United States
Website
- Description: Provider of integrated CDMO services for biologics, specializing in mammalian, microbial, and cell therapies. Offers biomanufacturing from pre-clinical to commercial, including analytical methods development, process development, cGMP manufacturing, product characterization, QC release testing, formulation development, and analytical testing, supported by a clinical-scale cGMP facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scorpius Biologics company profile →
Zwiers Regulatory
HQ: The Netherlands
Website
- Description: Provider of consulting services focused on integrated development for pharmaceuticals and devices, pharmacovigilance, and regulatory affairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zwiers Regulatory company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Corgenix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Corgenix
2.2 - Growth funds investing in similar companies to Corgenix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Corgenix
4.2 - Public trading comparable groups for Corgenix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →